- Home
- TRST vs PHAR Comparison
TRST vs PHAR Comparison
Compare TRST & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- PHAR
- Stock Information
- Founded
- TRST 1902
- PHAR 1988
- Country
- TRST United States
- PHAR Netherlands
- Employees
- TRST N/A
- PHAR N/A
- Industry
- TRST Major Banks
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- TRST Finance
- PHAR Health Care
- Exchange
- TRST Nasdaq
- PHAR Nasdaq
- Market Cap
- TRST 642.6M
- PHAR 627.5M
- IPO Year
- TRST N/A
- PHAR N/A
- Fundamental
- Price
- TRST $30.97
- PHAR $9.37
- Analyst Decision
- TRST
- PHAR Strong Buy
- Analyst Count
- TRST 0
- PHAR 3
- Target Price
- TRST N/A
- PHAR $27.00
- AVG Volume (30 Days)
- TRST 115.5K
- PHAR 7.2K
- Earning Date
- TRST 01-21-2025
- PHAR 10-24-2024
- Dividend Yield
- TRST 4.70%
- PHAR N/A
- EPS Growth
- TRST N/A
- PHAR N/A
- EPS
- TRST 2.48
- PHAR N/A
- Revenue
- TRST $168,593,000.00
- PHAR $285,745,000.00
- Revenue This Year
- TRST N/A
- PHAR $20.08
- Revenue Next Year
- TRST $11.69
- PHAR $9.22
- P/E Ratio
- TRST $12.33
- PHAR N/A
- Revenue Growth
- TRST N/A
- PHAR 30.64
- 52 Week Low
- TRST $25.83
- PHAR $6.65
- 52 Week High
- TRST $38.89
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- TRST 26.76
- PHAR 50.02
- Support Level
- TRST $30.15
- PHAR $9.56
- Resistance Level
- TRST $33.07
- PHAR $10.15
- Average True Range (ATR)
- TRST 0.80
- PHAR 0.60
- MACD
- TRST -0.28
- PHAR -0.10
- Stochastic Oscillator
- TRST 19.76
- PHAR 15.84
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.